Search Login Register

Raynaud Disease (Raynaud's Disease) Summary

Description: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

Also Known As: Raynaud's Disease; Raynauds Disease; Raynaud Phenomenon

Networked: 431 relevant articles (35 outcomes, 39 trials/studies) for this Disease

Key Drugs and Agents for Raynaud Disease

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Calcium : 3 outcomes 2 studies in 9 results : IBA
  2. Nicardipine (Dagan) : 2 outcomes 2 studies in 3 results : FDA 15 Generic
  3. Iloprost (Ventavis) : 2 outcomes in 5 results : FDA 1
  4. relcovaptan : 2 outcomes in 2 results : IBA
  5. Nifedipine (Adalat) : 1 outcome 2 studies in 15 results : FDA 25 Generic
  6. Nitroglycerin (Dynamite) : 1 outcome 2 studies in 5 results : FDA 53 Generic
  7. Phosphodiesterase 5 Inhibitors : 1 outcome 2 studies in 4 results : IBA
  8. Flunarizine : 1 outcome 2 studies in 2 results : IBA
  9. Idiopathic pulmonary hypertension : 1 outcome 1 study in 11 results : IBA
  10. Alprostadil (Muse) : 1 outcome 1 study in 6 results : FDA 8 Generic
Show All >>

Diseases Related to Raynaud Disease

  1. Systemic Scleroderma (Systemic Sclerosis)
  2. Ulcer
  3. Hyperhidrosis
  4. Migraine Disorders (Migraine)
  5. Hypertension (High Blood Pressure)
Show All >>

Key Therapies for Raynaud Disease

Efficacy Chart >>
  1. Sympathectomy (Sympathectomies) : 3 outcomes 1 study in 46 results
  2. Psychology Biofeedback (Biofeedback) : 2 outcomes 1 study in 24 results
  3. Tocolysis : 2 outcomes in 4 results
  4. Drug Therapy (Chemotherapy) : 1 outcome in 5 results
  5. Radiotherapy : 1 outcome in 3 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.